Fosun reportedly planning sale of India's $3.6 billion Gland Pharma

Quick Summary:

Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd.

Shares of Gland jumped as much as 5.7% in Mumbai following the Bloomberg News report, their largest intraday increase in almost a month.

Fosun reportedly planning sale of India's $3.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Dong Cao and Manuel Baigorri | Bloomberg

Category: EconomyFinance

Markets: IndiaHong Kong

Topics: Gland Sale Billion Listed News Planning India Fosun People Business Pharma

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2022-11-29 @ 13:39:00 (2 months ago)

News Timezone: GMT +5:00

Ranking: #1923 (out of 5756 stories this day)

News Source URL: business-standard.com

Language: English

Article Length: 416 words

Reading Time: 3 minutes read

Sentences: 21 lines

Sentence Length: 20 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 2028311

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 99 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions